Clinical trials
Withdrawn Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 12 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 21 |
| Fuda Cancer Hospital, Guangzhou | 7 |
| Zhejiang University | 6 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Eli Lilly and Company | 2 |
| Henan Cancer Hospital | 2 |
| Maternal and Child Health Hospital of Foshan | 2 |
| Peking University People's Hospital | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Shi Ming | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 13 |
| Lung Neoplasms | 6 |
| COVID-19 | 5 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Esophageal Squamous Cell Carcinoma | 5 |
| Breast Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Multiple Myeloma | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.